Alivus Life Sciences Ltd
NSE: ALIVUS BSE: 543322
₹1044.95
(-0.49%)
Wed, 06 May 2026, 05:13 pm
Market Cap128.92B
PE Ratio23.63
Dividend0.48
Health Technology
Pharmaceuticals: Major
24.5KAlivus Life Sciences Balance Sheet
| Particulars | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Interest expense on debt | 0 | -6.05M | -335.15M | -875.47M | -279.62M | -5.47M | -15.46M | -24.14M |
| Pretax equity in earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity in earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total assets | 850.00K | 14.78B | 17.26B | 19.99B | 24.72B | 27.04B | 28.55B | 34.19B |
| Total current assets | 840.00K | 9.31B | 11.60B | 13.99B | 17.65B | 18.50B | 19.16B | 23.35B |
| Cash and short term investments | 70.00K | 20.61M | 99.98M | 1.18B | 5.12B | 3.09B | 3.02B | 5.49B |
| Cash & equivalents | 70.00K | 20.61M | 99.98M | 1.16B | 5.12B | 3.09B | 3.02B | 712.36M |
| Short term investments | 0 | 0 | 0 | 28.05M | 0 | 0 | 0 | 4.78B |
| Total receivables, net | 310.00K | 5.23B | 7.28B | 7.51B | 7.20B | 8.91B | 8.56B | 10.10B |
| Accounts receivable - trade, net | 310.00K | 4.48B | 6.39B | 6.20B | 6.73B | 8.07B | 7.65B | 9.70B |
| Other receivables | 0 | 752.52M | 894.75M | 1.32B | 468.68M | 845.82M | 903.68M | 398.65M |
| Total inventory | 380.00K | 4.05B | 4.22B | 5.29B | 5.32B | 6.22B | 6.81B | 6.82B |
| Other current assets, total | 80.00K | 0 | 0 | — | 1.11M | 276.00M | 766.73M | 922.41M |
| Total non-current assets | 10.00K | 5.47B | 5.66B | 6.00B | 7.07B | 8.54B | 9.39B | 10.84B |
| Long term investments | 0 | 770.00K | 770.00K | 770.00K | 770.00K | 770.00K | 770.00K | 770.00K |
| Note receivable - long term | — | — | — | — | — | — | — | — |
| Investments in unconsolidated subsidiaries | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other investments | 0 | 770.00K | 770.00K | 770.00K | 770.00K | 770.00K | 770.00K | 770.00K |
| Net property/plant/equipment | 10.00K | 5.30B | 5.50B | 5.80B | 6.90B | 8.26B | 9.05B | 10.46B |
| Gross property/plant/equipment | 10.00K | 5.49B | 5.97B | 6.58B | 8.03B | 9.77B | 11.04B | 12.99B |
| Deferred tax assets | — | 22.85M | 1.31M | 20.26M | 10.74M | 18.12M | 45.50M | 73.15M |
| Net intangible assets | 0 | 63.99M | 71.68M | 79.11M | 103.80M | 180.01M | 148.53M | 199.37M |
| Goodwill, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other intangibles, net | 0 | 63.99M | 71.68M | 79.11M | 103.80M | 180.01M | 148.53M | 199.37M |
| Other long term assets, total | 0 | 78.94M | 84.32M | 96.97M | 55.60M | 82.14M | 147.02M | 105.58M |
| Short term debt | 0 | 210.00K | 210.00K | 0 | 16.80M | 22.65M | 23.87M | 56.48M |
| Current portion of LT debt and capital leases | 0 | 0 | 0 | 0 | 16.80M | 22.65M | 23.87M | 56.48M |
| Short term debt excl. current portion of LT debt | 0 | 210.00K | 210.00K | 0 | 0 | 0 | 0 | 0 |
| Accounts payable | 130.00K | 1.83B | 2.01B | 2.21B | 3.08B | 3.97B | 3.69B | 3.90B |
| Income tax payable | — | 23.54M | 83.60M | 136.93M | 120.03M | 70.78M | 0 | — |
| Long term debt | 0 | 0 | 0 | 0 | 12.04M | 170.92M | 147.61M | 509.58M |
| Long term debt excl. lease liabilities | 0 | 0 | 0 | 0 | 12.04M | 170.92M | 147.61M | 509.58M |
| Total equity | -13.98M | 881.25M | 4.02B | 7.53B | 20.54B | 21.38B | 23.32B | 28.17B |
| Shareholders' equity | -13.98M | 881.25M | 4.02B | 7.53B | 20.54B | 21.38B | 23.32B | 28.17B |
| Common equity, total | -13.98M | 881.25M | 4.02B | 7.53B | 20.54B | 21.38B | 23.32B | 28.17B |
| Other common equity | 0 | 0 | 0 | 0 | 34.98M | 66.83M | 110.58M | 99.69M |
| Total debt | 0 | 210.00K | 210.00K | 0 | 28.84M | 193.57M | 171.48M | 566.06M |
| Net debt | -70.00K | -20.40M | -99.77M | -1.18B | -5.09B | -2.90B | -2.84B | -4.92B |
| Change in accounts receivable | -310.00K | -930.52M | -1.98B | -410.20M | -592.15M | -1.34B | 378.60M | -2.05B |
| Change in taxes payable | — | — | — | — | — | — | — | — |
| Change in accounts payable | -4.83M | -590.17M | 193.02M | 340.89M | 737.49M | 981.77M | -341.21M | 187.46M |
| Change in other assets/liabilities | 0 | 0 | 0 | 0 | 881.29M | -735.63M | -551.93M | 445.20M |
| Sale of fixed assets & businesses | 0 | 0 | 2.93M | 16.34M | 4.69M | 1.74M | 4.65M | 6.29M |
| Purchase/sale of investments, net | 0 | 0 | 0 | -28.05M | 28.05M | 1.11M | 0 | -4.70B |
| Sale/maturity of investments | 0 | 0 | 0 | 0 | 28.05M | 1.11M | 0 | 0 |
| Purchase of investments | 0 | 0 | 0 | -28.05M | 0 | 0 | 0 | -4.70B |
| Other investing cash flow items, total | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Issuance/retirement of debt, net | 4.86M | -9.65M | -1.37B | -2.14B | -9.61B | 0 | 0 | 0 |
| Issuance/retirement of long term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Issuance/retirement of short term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Issuance/retirement of other debt | 4.86M | -9.65M | -1.37B | -2.14B | -9.61B | 0 | — | — |
| Total cash dividends paid | 0 | 0 | 0 | 0 | -1.29B | -3.86B | -2.76B | 0 |
| Other financing cash flow items, total | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800